Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: A phase I-II study
- 15 March 2007
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 67 (4), 1027-1036
- https://doi.org/10.1016/j.ijrobp.2006.10.015
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- 141 Gemcitabine: In vitro and in vivo evidence of its radiation sensitizing activity and studies using fluorine-19 magnetic resonance spectroscopy to determine an optimal gemcitabine dosing schedule - pre-clinical observations relevant to gemcitabine clinical trialsInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidineInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Schedule dependence of sensitivity to 2′,2′-difluorodeoxycytidine (gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumoursBiochemical Pharmacology, 1994
- Prognostic indicators for survival after resection of pancreatic adenocarcinomaThe American Journal of Surgery, 1993
- Treatment of Locally Unresectable Carcinoma of the Pancreas: Comparison of Combined-Modality Therapy (Chemotheraphy Plus Radiotherapy) to Chemotheraphy Alone1JNCI Journal of the National Cancer Institute, 1988
- Radiation therapy combined with adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinomaCancer, 1985
- Pancreatic CancerArchives of Surgery, 1985
- Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study.Journal of Clinical Oncology, 1985
- Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The gastrointestinal tumor study groupCancer, 1981